The Economic Standard published a white paper on Hydroxychloroquine which states that 1) Hydroxychloroquine (HCQ) is a safe, versatile medicine that has treated hundreds of millions of people for many diseases over seven decades. 2) Numerous controlled observational studies and meta-analyses have demonstrated that HCQ can help people with COVID-19. 3) Hundreds of drugs have been approved by the U.S. FDA on the basis of similar observational studies, especially when conducted in large numbers and subject to meta-analysis. 4) As a matter of medical practice and especially in a pandemic emergency, it is not the case that only randomized controlled trials can justify adopting a treatment. 5) HCQ should be more widely recommended, prescribed and promoted to treat COVID-19 right now." Download the Report.
Nevada reverses decision to block hydroxychloroquine